Inhaled coronavirus vaccines are under development — and could be more effective than an injection


Dozens of COVID-19 vaccines are under development worldwide, and the ones closest to ready for public use are traditional, injectable vaccines. But scientists in the U.S., the U.K., and Hong Kong are working on an alternative: inhaled vaccines, the South China Morning Post reports.
Most of the injected vaccines in testing would require multiple shots to be effective, and it's not entirely clear if COVID-19 antibodies will prevent an infection. Meanwhile, scientists have hypothesized, inhaled immunizations could be more effective than injections because they could stop the coronavirus at the place it's often contracted: the nose. Stopping the virus from growing in the nose could then prevent its transmission to others, Bloomberg notes. In addition, the respiratory system is full of mucus tissues full of immune proteins that an inhaled vaccine could bolster — not to mention that many people simply don't like shots.
"The first generation of vaccines are probably going to protect a lot of people," Michael Diamond, an infectious disease specialist at Washington University in St. Louis, told Bloomberg. "But I think it's the second- and third-generation vaccines — and maybe intranasal vaccines will be a key component of this — that ultimately are going to be necessary." His team studied mice and found an inhaled vaccine "created a strong immune response throughout the body," especially in the respiratory system, Bloomberg notes.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Kathryn is a graduate of Syracuse University, with degrees in magazine journalism and information technology, along with hours to earn another degree after working at SU's independent paper The Daily Orange. She's currently recovering from a horse addiction while living in New York City, and likes to share her extremely dry sense of humor on Twitter.
-
How will the new Repayment Assistance Plan for student loans work?
the explainer The Repayment Assistance Plan (RAP) will replace existing income-driven repayment plans
-
In the Spotlight Venezuelan President Nicolás Maduro has been at odds with US forces
-
Music reviews: Ethel Cain, Amaarae, and The Black Keys
Feature "Willoughby Tucker, I'll Always Love You," "Black Star," and "No Rain, No Flowers"
-
Texas declares end to measles outbreak
Speed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC